A 52-week update of a multicentre Italian real-world experience on effectiveness and safety of dupilumab in adolescents with moderate-to-severe atopic dermatitis

被引：17

作者：

Stingeni, Luca ^{[1
]}

Bianchi, Leonardo ^{[1
]}

Antonelli, Elettra ^{[1
]}

Caroppo, Elena Sofia ^{[1
]}

Ferrucci, Silvia Mariel ^{[2
]}

Gurioli, Carlotta ^{[3
]}

Ortoncelli, Michela ^{[4
]}

Fabbrocini, Gabriella ^{[5
]}

Nettis, Eustachio ^{[6
]}

Schena, Donatella ^{[7
]}

Napolitano, Maddalena ^{[8
]}

Gola, Massimo ^{[9
]}

Bonzano, Laura ^{[10
]}

Rossi, MariaTeresa ^{[11
]}

Belloni Fortina, Anna ^{[12
]}

Balato, Anna ^{[13
]}

Peris, Ketty ^{[14
]}

Foti, Caterina ^{[15
]}

Guarneri, Fabrizio ^{[16
]}

Romanelli, Marco ^{[17
]}

Patruno, Cataldo ^{[18
]}

Savoia, Paola ^{[19
]}

Esposito, Maria ^{[20
]}

Russo, Filomena ^{[21
]}

Errichetti, Enzo ^{[22
]}

Bianchelli, Tommaso ^{[23
]}

Bianchi, Luca ^{[24
]}

Pellacani, Giovanni ^{[25
]}

Feliciani, Claudio ^{[26
]}

Offidani, Annamaria ^{[27
]}

Corazza, Monica ^{[28
]}

Micali, Giuseppe ^{[29
]}

Milanesi, Nicola ^{[30
]}

Malara, Giovanna ^{[31
]}

Chiricozzi, Andrea ^{[14
]}

Tramontana, Marta ^{[1
]}

Hansel, Katharina ^{[1
]}

机构：

[1] Univ Perugia, Dept Med & Surg, Dermatol Sect, I-06129 Perugia, Italy

[2] Fdn IRCCS Ca Granda Osped Maggiore Policlin, Dermatol Unit, Milan, Italy

[3] AlmaMater Studiorum Univ Bologna, IRCCS Policlin St Orsola, Dermatol Div, Dept Expt Diagnost & Specialty Med DIMES, Bologna, Italy

[4] Univ Turin, Dept Med Sci, Div Dermatol, Turin, Italy

[5] Univ Naples Federico II, Dept Clin Med & Surg, Sect Dermatol, Naples, Italy

[6] Univ Bari, Dept Emergency & Organ Transplantat Allergol & Cl, Bari, Italy

[7] Univ Verona, Dept Med, Sect Dermatol & Venereol, Verona, Italy

[8] Univ Molise, Dept Med & Hlth Sci Vincenzo Tiberio, Campobasso, Italy

[9] Univ Florence, Dept Hlth Sci, Unit Allergol & Pediat Dermatol, Florence, Italy

[10] Azienda USL IRCCS Reggio Emilia, Dermatol Unit, Arcispedale Santa Maria Nuova, Reggio Emilia, Italy

[11] Univ Brescia, Dept Dermatol, ASST Spedali Civili Brescia, Brescia, Italy

[12] Univ Padua, Dept Med DIMED, Unit Dermatol, Padua, Italy

[13] Univ Campania Luigi Vanvitelli, Unit Dermatol, Naples, Italy

[14] Catholic Univ, Inst Dermatol, Rome, Italy

[15] Univ Bari, Dept Biomed Sci & Human Oncol, Sect Dermatol, Bari, Italy

[16] Univ Messina, Dept Clin & Expt Med, Sect Dermatol, Messina, Italy

[17] Univ Pisa, Dermatol Unit, Pisa, Italy

[18] Magna Graecia Univ Catanzaro, Hlth Sci Dept, Sect Dermatol, Catanzaro, Italy

[19] Univ Piemonte Orientale, Dept Hlth Sci, Dermatol Clin, Novara, Italy

[20] Univ Aquila, Dept Biotechnol & Appl Clin Sci, Dermatol, Laquila, Italy

[21] Univ Siena, Dept Clin Surg Med & Neurosci, Sect Dermatol, Siena, Italy

[22] Univ Udine, Inst Dermatol, Dept Med DAME, Udine, Italy

[23] INRCA IRCCS Hosp, Ist Nazl Riposo & Cura Anziani, Dermatol Unit, Ancona, Italy

[24] Univ Tor Vergata, Syst Med Dept, Dermatol Unit, Rome, Italy

[25] Sapienza Univ Rome, Dept Dermatol, Policlin Umberto I, Rome, Italy

[26] Univ Parma, Dept Clin & Expt Med, Sect Dermatol, Parma, Italy

[27] Polytech Marche Univ, Clin & Mol Sci Dept, Dermatol Clin, Ancona, Italy

[28] Univ Ferrara, Dept Med Sci, Sect Dermatol, Ferrara, Italy

[29] Univ Catania, Dermatol Clin, Catania, Italy

[30] Univ Florence, Dept Surg & Translat Med, Allergol & Occupat Dermatol Unit, Florence, Italy

[31] Grande Osped Metropolitano, Dermatol Unit, Reggio Di Calabria, Italy

来源：

JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY | 2023年 / 37卷 / 03期

关键词：

D O I：

10.1111/jdv.18648

中图分类号：

R75 [皮肤病学与性病学];

学科分类号：

100206 ;

摘要：

引用

页码：E384 / E388

页数：5

共 50 条

[1] Moderate-to-severe atopic dermatitis in adolescents treated with dupilumab: A multicentre Italian real-world experience
Stingeni, L.
Bianchi, L.
Antonelli, E.
Caroppo, E. S.
Ferrucci, S. M.
Ortoncelli, M.
Fabbrocini, G.
Nettis, E.
Schena, D.
Napolitano, M.
Gola, M.
Bonzano, L.
Rossi, M.
Fortina, A. Belloni
Balato, A.
Peris, K.
Foti, C.
Guarneri, F.
Romanelli, M.
Patruno, C.
Savoia, P.
Fargnoli, M. C.
Russo, F.
Errichetti, E.
Bianchelli, T.
Bianchi, L.
Pellacani, G.
Feliciani, C.
Offidani, A.
Corazza, M.
Micali, G.
Milanesi, N.
Malara, G.
Chiricozzi, A.
Tramontana, M.
Hansel, K.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2022, 36 (08) : 1292 - 1299
[2] Effectiveness and safety of upadacitinib for moderate-to-severe atopic dermatitis in a real-world setting: A 52-week retrospective study
Gargiulo, L.
Ibba, L.
Piscazzi, F.
Alfano, A.
Ingurgio, R. Cascio
Valenti, M.
Costanzo, A.
Narcisi, A.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2024, 38 (02) : e152 - e154
[3] Real-world effectiveness and safety of dupilumab in managing children and adolescents with moderate-to-severe atopic dermatitis
Marshall, Claire
Littlewood, Zoe
Herety, Nichola
Heal, Calvin
Sharif, Jennifer
Clayton, Tim
BRITISH JOURNAL OF DERMATOLOGY, 2022, 187 : 196 - 196
[4] Effectiveness and safety of dupilumab in adolescents with moderate-to-severe atopic dermatitis: a preliminary report of real-world data
Ferrucci, Silvia M.
Maronese, Carlo A.
Tavecchio, Simona
Angileri, Luisa
Genovese, Giovanni
Marzano, V. Angelo
ITALIAN JOURNAL OF DERMATOLOGY AND VENEREOLOGY, 2022, 157 (02) : 211 - 213
[5] Real-world experience of dupilumab in the treatment of moderate-to-severe atopic dermatitis
Kim, Nicole S.
Maliyar, Khalad
Oliveira, Luciana
O'Toole, Ashley
Gooderham, Melinda J.
INTERNATIONAL JOURNAL OF DERMATOLOGY, 2020, 59 (10) : E361 - E363
[6] A 24-weeks real-world experience of dupilumab in adolescents with moderate-to-severe atopic dermatitis
Napolitano, Maddalena
Fabbrocini, Gabriella
Potestio, Luca
Fontanella, Giuseppina
Picone, Vincenzo
Bennardo, Luigi
Scalvenzi, Massimiliano
Patruno, Cataldo
DERMATOLOGIC THERAPY, 2022, 35 (08)
[7] A 48-week update of a multicentre real-life experience of dupilumab in adult patients with moderate-to-severe atopic dermatitis
Fargnoli, M. C.
Esposito, M.
Ferrucci, S.
Girolomoni, G.
Offidani, A.
Patrizi, A.
Peris, K.
Costanzo, A.
Malara, G.
Pellacani, G.
Romanelli, M.
Amerio, P.
Cristaudo, A.
Flori, M. L.
Motolese, A.
Betto, P.
Patruno, C.
Pigatto, P.
Peccianti, C.
Stinco, G.
Zalaudek, I.
Bianchi, L.
Boccaletti, V.
Cannavo, S. P.
Cusano, F.
Lembo, S.
Mozzillo, R.
Gallo, R.
Potenza, C.
Rongioletti, F.
Tiberio, R.
Grieco, T.
Micali, G.
Persechino, S.
Pettinato, M.
Pucci, S.
Stingeni, L.
Caruso, C.
Argenziano, G.
JOURNAL OF DERMATOLOGICAL TREATMENT, 2022, 33 (02) : 1146 - 1149
[8] Real-world experience of dupilumab for patients with moderate-to-severe atopic dermatitis in a tertiary care setting
Kreeshan, F. C.
Lavery, D.
Clarke, S.
Warren, R. B.
Hunter, H. J. A.
BRITISH JOURNAL OF DERMATOLOGY, 2020, 183 : 70 - 70
[9] Real-world effectiveness and safety of dupilumab in patients with moderate and severe atopic dermatitis: 2-year experience
Fujiwara, Chisako
Uchiyama, Akihiko
Inoue, Yuta
Ishikawa, Mai
Motegi, Sei-ichiro
JOURNAL OF CUTANEOUS IMMUNOLOGY AND ALLERGY, 2023, 6 (03) : 88 - 93
[10] Real-World Effectiveness and Safety of Lebrikizumab for Moderate-to-Severe Atopic Dermatitis: A 16-Week Study in Japan
Hagino, Teppei
Uchiyama, Akihiko
Onda, Marina
Kosaka, Keiji
Araki, Takeshi
Motegi, Sei-ichiro
Saeki, Hidehisa
Fujimoto, Eita
Kanda, Naoko
DERMATITIS, 2025,

← 1 2 3 4 5 →